Article
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
The Journal of clinical investigation - 1 Jun 2014
Yang Yanan, Ahn Young-Ho, Chen Yulong, Tan Xiaochao, Guo Lixia, Gibbons Don L, Ungewiss Christin, Peng David H, Liu Xin, Lin Steven H, Thilaganathan Nishan, Wistuba Ignacio I, Rodriguez-Canales Jaime, McLendon Georgia, Creighton Chad J, Kurie Jonathan M
Abstract excerpt
Epithelial tumor cells that have undergone epithelial-to-mesenchymal transition (EMT) are typically prone to metastasis and drug resistance and contribute to a poor clinical outcome. The transcription factor ZEB1 is a known driver of EMT, and mediators of ZEB1 represent potential therapeutic targets for metastasis suppression. Here, we have shown that phosphatidylinositol 3-kinase-targeted (PI3K-targeted) therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
